TY - JOUR
T1 - Differences among hepatitis c patients seen in community and specialist outpatient care settings
AU - Materniak, Stefanie
AU - Bland, Samantha
AU - Margeson, Alyssa
AU - Webster, Duncan
AU - Smyth, Daniel
AU - O’brien, Meaghan
N1 - Publisher Copyright:
© 2020, University of Toronto Press Inc. All rights reserved.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - BACKGROUND: In the province of New Brunswick, care for patients infected with hepatitis C is provided in both community-based care settings and specialist-based care settings, but little is known about the differences between these populations. The aim of the current study is to characterize the demographic, socioeconomic, mental health and substance use factors of patients seen in these settings. METHODS: Enrolling sites for this study included four specialist office-based clinics and one community-based clinic in three communities in New Brunswick. Personal health data was collected with informed consent via questionnaires and medical records. Non-incarcerated patients seen between April 2014 and April 2016 were included in the analysis. RESULTS: A total of 374 patients were included (34.8% community versus 65.2% specialist office). Patients seen in the community care setting were younger (median age 43.7 versus 49.1 years), less likely to have a primary care provider (p =.007), rely on social assistance as regular source of income (p <.001), have been incarcerated (p =.007), reported sharing drug paraphernalia (p =.025), had recent injection drug use (p <.001), reported snorting drugs recently (p <.001) and reported prior overdose (p =.025). Community clinic patients also had significantly younger mean age at first use of alcohol (13.6 versus 14.7 years, p =.044), marijuana (14.6 versus 15.8, p =.040), and opioids (23.9 versus 26.5 years, p =.036) over those seen in specialist offices. CONCLUSIONS: Unique differences exist between patients seen in community and specialist care settings in New Brunswick. Understanding these differences is an essential first step in developing patient-centred care models.
AB - BACKGROUND: In the province of New Brunswick, care for patients infected with hepatitis C is provided in both community-based care settings and specialist-based care settings, but little is known about the differences between these populations. The aim of the current study is to characterize the demographic, socioeconomic, mental health and substance use factors of patients seen in these settings. METHODS: Enrolling sites for this study included four specialist office-based clinics and one community-based clinic in three communities in New Brunswick. Personal health data was collected with informed consent via questionnaires and medical records. Non-incarcerated patients seen between April 2014 and April 2016 were included in the analysis. RESULTS: A total of 374 patients were included (34.8% community versus 65.2% specialist office). Patients seen in the community care setting were younger (median age 43.7 versus 49.1 years), less likely to have a primary care provider (p =.007), rely on social assistance as regular source of income (p <.001), have been incarcerated (p =.007), reported sharing drug paraphernalia (p =.025), had recent injection drug use (p <.001), reported snorting drugs recently (p <.001) and reported prior overdose (p =.025). Community clinic patients also had significantly younger mean age at first use of alcohol (13.6 versus 14.7 years, p =.044), marijuana (14.6 versus 15.8, p =.040), and opioids (23.9 versus 26.5 years, p =.036) over those seen in specialist offices. CONCLUSIONS: Unique differences exist between patients seen in community and specialist care settings in New Brunswick. Understanding these differences is an essential first step in developing patient-centred care models.
UR - http://www.scopus.com/inward/record.url?scp=85136757477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136757477&partnerID=8YFLogxK
U2 - 10.3138/canlivj-2019-0003
DO - 10.3138/canlivj-2019-0003
M3 - Article
AN - SCOPUS:85136757477
SN - 2561-4444
VL - 3
SP - 286
EP - 293
JO - Canadian Liver Journal
JF - Canadian Liver Journal
IS - 3
ER -